277 related articles for article (PubMed ID: 14558407)
1. Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus.
Schadlow MB; Anhalt GJ; Sinha AA
J Drugs Dermatol; 2003 Oct; 2(5):564-7. PubMed ID: 14558407
[TBL] [Abstract][Full Text] [Related]
2. Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature.
Barnadas M; Roe E; Brunet S; Garcia P; Bergua P; Pimentel L; Puig L; Francia A; García R; Gelpí C; Sierra J; Coll P; Alomar A
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):69-74. PubMed ID: 16405612
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
Heizmann M; Itin P; Wernli M; Borradori L; Bargetzi MJ
Am J Hematol; 2001 Feb; 66(2):142-4. PubMed ID: 11421295
[TBL] [Abstract][Full Text] [Related]
4. Off-label uses of rituximab in dermatology.
Carr DR; Heffernan MP
Dermatol Ther; 2007; 20(4):277-87. PubMed ID: 17970893
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy.
Hoque SR; Black MM; Cliff S
Clin Exp Dermatol; 2007 Mar; 32(2):172-5. PubMed ID: 17342796
[TBL] [Abstract][Full Text] [Related]
6. PNP with Waldenström's macroglobulinaemia.
Perera GK; Devereux S; Mufti G; Salisbury J; Creamer D
Clin Exp Dermatol; 2005 Jan; 30(1):27-9. PubMed ID: 15663497
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
[TBL] [Abstract][Full Text] [Related]
8. Anti-B- cell-directed immunotherapy (rituximab) in the treatment of refractory pemphigus--an update.
Arin MJ; Hunzelmann N
Eur J Dermatol; 2005; 15(4):224-30. PubMed ID: 16048747
[TBL] [Abstract][Full Text] [Related]
9. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
[TBL] [Abstract][Full Text] [Related]
10. [A case of follicular lymphoma complicated with lethal pemphigus].
Imataki O; Tamai Y; Abe Y; Ito I; Yoshikawa S; Kawakami K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
[TBL] [Abstract][Full Text] [Related]
11. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia.
Hohwy T; Bang K; Steiniche T; Peterslund NA; d'Amore F
Eur J Haematol; 2004 Sep; 73(3):206-9. PubMed ID: 15287918
[TBL] [Abstract][Full Text] [Related]
12. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus.
Borradori L; Lombardi T; Samson J; Girardet C; Saurat JH; Hügli A
Arch Dermatol; 2001 Mar; 137(3):269-72. PubMed ID: 11255323
[No Abstract] [Full Text] [Related]
14. Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
Bech R; Baumgartner-Nielsen J; Peterslund NA; Steiniche T; Deleuran M; d'Amore F
Br J Dermatol; 2013 Aug; 169(2):469-72. PubMed ID: 23517368
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone.
Martínez De Pablo MI; Iranzo P; Mascaró JM; Llambrich A; Baradad M; Herrero C
Acta Derm Venereol; 2005; 85(3):233-5. PubMed ID: 16040408
[TBL] [Abstract][Full Text] [Related]
16. A nonfatal case and 2 fatal cases of paraneoplastic pemphigus: can a complement indirect immunofluorescent test help to identify fatal "group A" paraneoplastic pemphigus cases?
Beutner EH; Pelton S; Hashimoto T; Xu Y; Plunkett RW; Korman NJ; Helm TN; Jablonska S
J Am Acad Dermatol; 2002 Dec; 47(6):841-51. PubMed ID: 12451367
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Plumb R; Doolittle GC
Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
[TBL] [Abstract][Full Text] [Related]
18. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
Taintor AR; Leiferman KM; Hashimoto T; Ishii N; Zone JJ; Hull CM
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S73-6. PubMed ID: 17434044
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
Allen KJ; Wolverton SE
J Drugs Dermatol; 2007 Sep; 6(9):883-9. PubMed ID: 17941359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]